{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T15:57:20Z","timestamp":1720627040537},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T00:00:00Z","timestamp":1391558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ijid.2013.12.018","type":"journal-article","created":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T18:52:03Z","timestamp":1391885523000},"page":"78-82","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serum HBsAg level and its clinical significance in lamivudine treatment for patients with HBeAg-negative acute-on-chronic liver failure"],"prefix":"10.1016","volume":"22","author":[{"given":"Jing","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-xia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-sheng","family":"Jie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-min","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2013.12.018_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute on chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijid.2013.12.018_bib0010","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1440-1746.2009.06089.x","article-title":"Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure","volume":"25","author":"Sun","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0015","first-page":"481","article-title":"The clinic features and the short-term efficacy of entecavir treatment of the HBeAg negative acute-on-chronic hepatitis B liver failure","volume":"22","author":"Shu","year":"2008","journal-title":"Chinese J Exp Clin Virol (Chin)"},{"key":"10.1016\/j.ijid.2013.12.018_bib0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/00365520701745693","article-title":"Role of genotype and precore\/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation","volume":"43","author":"Tsai","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0025","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2893.2009.01254.x","article-title":"Hepatitis B virus genotype and basal core promoter\/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis","volume":"17","author":"Ren","year":"2010","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijid.2013.12.018_bib0030","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199807093390201","article-title":"One year trial of lamivudine for chronic hepatitis B","volume":"339","author":"Lai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.12.018_bib0035","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199910213411702","article-title":"Lamivudine as initial treatment for chronic hepatitis B in the United States","volume":"341","author":"Dienstag","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2013.12.018_bib0040","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.21627","article-title":"Management of hepatitis B: summary of a clinical research workshop","volume":"45","author":"Hoofnagle","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2013.12.018_bib0045","first-page":"PP05","article-title":"Serum HBsAg quantification can predict sustained response to lamivudine in patients with negative HBeAg: a long-term post-treatment study","volume":"5","author":"Chan","year":"2011","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ijid.2013.12.018_bib0050","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3851\/IMP1921","article-title":"Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen negative patients","volume":"16","author":"Chan","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ijid.2013.12.018_bib0055","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1111\/j.1365-2893.2011.01473.x","article-title":"Serum hepatitis B surface antigen monitoring in long-term lamivudine-treated hepatitis B virus patients","volume":"18","author":"Gramenzi","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ijid.2013.12.018_bib0060","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy","volume":"126","author":"Werle-Lapostolle","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijid.2013.12.018_bib0065","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.cgh.2007.09.005","article-title":"Serum hepatitis B surface antigen quantification can reflect hepatitis B virus in the liver and predict treatment response","volume":"5","author":"Chan","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0070","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2010.01.007","article-title":"Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia","volume":"52","author":"Nguyen","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0075","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jhep.2010.01.014","article-title":"Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective","volume":"52","author":"Jaroszewicz","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0080","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/hep.23571","article-title":"Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers","volume":"51","author":"Thompson","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2013.12.018_bib0085","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jhep.2011.06.006","article-title":"Hepatitis B surface antigen quantification: why and how to use it in 2011\u2014A core group report","volume":"55","author":"Chan","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0090","first-page":"20","article-title":"Relationship between HBsAg level and HBV DNA level as well as illness severity in patients with HBV-related acute-on-chronic liver failure","volume":"34","author":"Li","year":"2011","journal-title":"Chin J Postgrad Med (Chin)"},{"key":"10.1016\/j.ijid.2013.12.018_bib0095","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1128\/CVI.05122-11","article-title":"Multicenter evaluation of the Elecsys hepatitis B surface antigen quantitative assay","volume":"18","author":"Zacher","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0100","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/jmv.21706","article-title":"Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays","volume":"82","author":"Louisirirotchanakul","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00430-009-0127-4","article-title":"Multicentre evaluation of the Elecsys hepatitis B surface antigen II assay for detection of HBsAg in comparison with other commercially available assays","volume":"198","author":"Jia","year":"2009","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135965350701200107","article-title":"Prediction of treatment related HBsAg loss in HBeAg-negative chronic hepatitis B: a clue from serum HBsAg levels","volume":"12","author":"Manesis","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.ijid.2013.12.018_bib0115","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/hep.22760","article-title":"Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B","volume":"49","author":"Brunetto","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ijid.2013.12.018_bib0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","article-title":"Patients with acute on chronic liver failure display \u2018sepsis-like\u2019 immune paralysis","volume":"42","author":"Wasmuth","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00428-011-1115-9","article-title":"Liver histology as predictor of outcome in patients with acute-on-chronic liver failure (ACLF)","volume":"459","author":"Rastogi","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ijid.2013.12.018_bib0130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jhep.2009.12.020","article-title":"A new role for an old marker, HBsAg","volume":"52","author":"Brunetto","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2013.12.018_bib0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/1319-3767.93805","article-title":"Clinical implication of HBsAg quantification in patients with chronic hepatitis B","volume":"18","author":"Vigano","year":"2012","journal-title":"Saudi J Gastroenterol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214000320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971214000320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T10:39:13Z","timestamp":1688985553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971214000320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":27,"alternative-id":["S1201971214000320"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2013.12.018","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum HBsAg level and its clinical significance in lamivudine treatment for patients with HBeAg-negative acute-on-chronic liver failure","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2013.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}